A Case of Multidrug-Resistant (MDR) Tuberculosis and HIV Co-Infection

被引：1

作者：

Torres, Sebastian G. Vila ^{[1
]}

Fullmer, Jessie ^{[1
]}

Berkowitz, Leonard ^{[2
]}

机构：

[1] Brooklyn Hosp Ctr, Internal Med, Brooklyn, NY 11201 USA

[2] Brooklyn Hosp Ctr, Infect Dis, Brooklyn, NY USA

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 04期

关键词：

coinfection; multidrug-resistant pathogen; pulmonary tuberculosis; tuberculosis; hiv;

D O I：

10.7759/cureus.37033

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pulmonary tuberculosis (TB) infection is a public health concern in the United States. Mycobacterium tuberculosis antimicrobial resistance is a global public health concern. We present a case of a young man from Venezuela who presented to a hospital in New York and was newly diagnosed with pulmonary tuberculosis, human immunodeficiency virus (HIV), and syphilis. His TB isolate was found to be resistant to multiple anti-TB drugs, presenting unusual challenges in treating multidrug-resistant TB with HIV coinfection.

引用

页数：4

共 11 条

[1]

[Anonymous], 2022, About us

[2]

[Anonymous], 2022, VENEZUELA CRISIS

[3]

[Anonymous], 2022, TB MORTALITY

[4]

cdc, 2023, TB DATA STAT

[5]

clinicalinfo, 2023, GUIDELINES PREVENTIO

[6] Treatment of Highly Drug-Resistant Pulmonary Tuberculosis [J].

Conradie, Francesca ;

Diacon, Andreas H. ;

Ngubane, Nosipho ;

Howell, Pauline ;

Everitt, Daniel ;

Crook, Angela M. ;

Mendel, Carl M. ;

Egizi, Erica ;

Moreira, Joanna ;

Timm, Juliano ;

McHugh, Timothy D. ;

Wills, Genevieve H. ;

Bateson, Anna ;

Hunt, Robert ;

Van Niekerk, Christo ;

Li, Mengchun ;

Olugbosi, Morounfolu ;

Spigelman, Melvin .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10) :893-902

[7]

Factsheet, 2022, FACTSHEET 2022 TB HI

[8] Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis [J].

Isaakidis, P. ;

Casas, E. C. ;

Das, M. ;

Tseretopoulou, X. ;

Ntzani, E. E. ;

Ford, N. .

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (08) :969-978

[9]

ncbi, 2022, TREATMENT DRUG RESIS

[10]

ncbi, 2021, WHO RECOMMENDATIONS

← 1 2 →